-
Introduction An abdominal aortic aneurysm (AAA) is a bulging or weakening in the wall of the abdominal aorta, the largest blood vessel in the body. If left untreated, it can […]
-
For the 30 million Americans living with Type 2 diabetes, getting quality sleep is often a challenge. Sleep difficulties and diabetes are closely linked, and the issue tends to worsen […]
-
Diabetes is one of the most common health conditions globally, affecting millions of people. In the United States, about 11.6% of individuals are living with the condition, with Type 2 […]
-
New research suggests that drinking sparkling water might help with weight loss, but the effects are quite small.Westend61/Getty Images When people seek to lose weight, they often ditch sugary sodas […]
-
To address the GLP-1 drug shortages, manufacturer Eli Lilly has ramped up production of Mounjaro and Zepbound.Scott Olson/Getty Images Zepbound and Mounjaro have been on the Food and Drug Administration’s […]
-
Recent findings from Eli Lilly’s clinical trial reveal that tirzepatide significantly reduces the risk of type 2 diabetes while helping with long-term weight management. A new clinical trial from Eli […]
-
Eli Lilly’s new clinical trial shows Zepbound outperforms Wegovy in sustained weight loss results, providing hope for those battling obesity. In the ongoing battle against obesity, weight loss medications have […]
-
GLP-1 medications, including popular drugs like Ozempic, Wegovy, Mounjaro, and Zepbound, have gained immense popularity for their role in weight loss and managing diabetes. New research has highlighted their positive […]